GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,246 | -5,006 | 471 | -4,940 | -3,109 |
| Depreciation Amortization | 734 | 803 | 851 | 467 | 154 |
| Income taxes - deferred | N/A | N/A | N/A | -12 | N/A |
| Accounts receivable | N/A | 145 | 14 | 133 | -26 |
| Accounts payable and accrued liabilities | N/A | 252 | -49 | 64 | -142 |
| Other Working Capital | 380 | 561 | 157 | 811 | -769 |
| Other Operating Activity | 195 | 3,076 | -2,105 | 2,806 | 1,799 |
| Operating Cash Flow | $-937 | $-169 | $-661 | $-671 | $-2,093 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -64 | -33 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -2,808 |
| Purchase Of Investment | N/A | N/A | N/A | -3,060 | -3,060 |
| Sale Of Investment | N/A | N/A | N/A | 3,060 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -93 | -44 | -172 |
| Other Investing Activity | 0 | 0 | -93 | -44 | -172 |
| Investing Cash Flow | $N/A | $N/A | $-93 | $-108 | $-6,073 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 3,666 | 3,060 |
| Debt Issued | 2,233 | N/A | N/A | N/A | N/A |
| Debt Repayment | -25 | N/A | N/A | 1,350 | N/A |
| Common Stock Issued | N/A | N/A | 500 | 70 | 285 |
| Other Financing Activity | 0 | 0 | 0 | -3,713 | 748 |
| Financing Cash Flow | $2,208 | $N/A | $500 | $1,373 | $4,093 |
| Beginning Cash Position | 22 | 191 | 445 | 614 | 4,687 |
| End Cash Position | 1,293 | 22 | 191 | 1,208 | 614 |
| Net Cash Flow | $1,271 | $-169 | $-254 | $594 | $-4,073 |
| Free Cash Flow | |||||
| Operating Cash Flow | -937 | -169 | -661 | -671 | -2,093 |
| Capital Expenditure | N/A | N/A | N/A | -64 | -33 |
| Free Cash Flow | -937 | -169 | -661 | -735 | -2,126 |